Health-economic burden attributable to novel serotypes in candidate 24- and 31-valent pneumococcal conjugate vaccines

Related articles

1. A flexible agent-based modelling framework of multi-serotype pneumococcal carriage to evaluate vaccine strategies in large populations

   This article has 10 authors:

   1. Nefel Tellioglu
   2. David Price
   3. Xinghui Chen
   4. Violeta Spirkoska
   5. Yingying Wang
   6. Robert Moss
   7. Natalie Carvalho
   8. Kylie Carville
   9. Patricia T. Campbell
   10. Jodie McVernon

2. Examining the Pervasiveness of the Impact of COVID-19 and Associated Lockdown Policies on Pneumococcal Conjugate Vaccine (PCV) Coverage

   This article has 2 authors:

   1. Ruoxuan Wang
   2. Bryan N. Patenaude

3. Development and Clinical Application of Pneumococcal Vaccines

   This article has 8 authors:

   1. Yeqi Zheng
   2. Weiri Tan
   3. Zhikun Wu
   4. Lijun Wang
   5. Hui Liang
   6. Lu Zhou
   7. Ruoqing Chen
   8. Xu C. Chen